Skip to main content
Top
Published in: BMC Medicine 1/2022

Open Access 01-12-2022 | Photodynamic Therapy | Research article

A novel 450-nm laser-mediated sinoporphyrin sodium-based photodynamic therapy induces autophagic cell death in gastric cancer through regulation of the ROS/PI3K/Akt/mTOR signaling pathway

Authors: Xing Li, Lijiang Gu, Yuhang Chen, Xiaobing Wang, Yibo Mei, Jinlai Zhou, Minghai Ma, Jianbin Ma, Yue Chong, Xinyang Wang, Peng Guo, Dalin He, Jin Zeng

Published in: BMC Medicine | Issue 1/2022

Login to get access

Abstract

Background

Photodynamic therapy (PDT) has become an ideal and promising therapeutic method for fighting cancer, but its common application in clinical practice is prevented by the limitations of expensive devices in light sources and phototoxicity in photosensitizers. The aim of this study was to explore the antitumor efficiency of the novel 450-nm blue laser (BL) combined with sinoporphyrin sodium (DVDMS)-mediated PDT against human gastric cancer (GC) in vitro and in vivo, focusing on autophagy pathway.

Methods

Cell viability was detected by Cell Counting Kit-8 and colony formation assays in HGC27, MGC803, AGS, and GES-1 cells. Cell apoptosis was measured by flow cytometry and western blotting. The production of reactive oxygen species (ROS) was measured by fluorescence microscopy and flow cytometry. Autophagy was determined by transmission electron microscopy and western blotting. The antitumor effect of BL-PDT in vivo was detected by a subcutaneous tumor model in nude mice.

Results

The novel 450-nm laser-mediated DVDMS-based PDT caused remarkable growth inhibition and apoptosis induction in GC cells in vitro by the production of excessive ROS. Autophagy flux was induced by BL-PDT in GC cells, as determined by LC3 conversion assay, LC3 turnover assay, and mRFP-GFP-LC3 puncta assay. Furthermore, autophagy induction was demonstrated to positively contribute to BL-PDT-induced apoptotic effects on GC cells. Mechanically, ROS/PI3K/Akt/mTOR pathway was identified to involve in the regulation of BL-PDT-induced autophagy as determined by transcriptomic analysis and functional studies. Consistently, xenograft studies confirmed the significant antitumor effect of BL-PDT and its favorable safety in vivo.

Conclusions

The novel 450-nm laser-mediated DVDMS-based PDT may be a safe and effective approach against GC. Our results thus provide compelling evidence for the therapeutic application of BL-PDT in human GC.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wu H, Fu M, Liu J, Chong W, Fang Z, Du F, et al. The role and application of small extracellular vesicles in gastric cancer. Mol Cancer. 2021;20(1):71.CrossRef Wu H, Fu M, Liu J, Chong W, Fang Z, Du F, et al. The role and application of small extracellular vesicles in gastric cancer. Mol Cancer. 2021;20(1):71.CrossRef
2.
go back to reference Qin Y, Tong X, Fan J, Liu Z, Zhao R, Zhang T, et al. Global burden and trends in incidence, mortality, and disability of stomach cancer from 1990 to 2017. Clin Transl Gastroenterol. 2021;12(10):e00406.CrossRef Qin Y, Tong X, Fan J, Liu Z, Zhao R, Zhang T, et al. Global burden and trends in incidence, mortality, and disability of stomach cancer from 1990 to 2017. Clin Transl Gastroenterol. 2021;12(10):e00406.CrossRef
3.
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRef Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRef
4.
go back to reference Jin GF, Lv J, Yang M, Wang MY, Zhu M, Wang TOP, et al. Genetic risk, incident gastric cancer, and healthy lifestyle: a meta-analysis of genome-wide association studies and prospective cohort study. Lancet Oncol. 2020;21(10):1378–86.CrossRef Jin GF, Lv J, Yang M, Wang MY, Zhu M, Wang TOP, et al. Genetic risk, incident gastric cancer, and healthy lifestyle: a meta-analysis of genome-wide association studies and prospective cohort study. Lancet Oncol. 2020;21(10):1378–86.CrossRef
5.
go back to reference Wang TY, Cai H, Sasazuki S, Tsugane S, Zheng W, Cho ER, et al. Fruit and vegetable consumption, Helicobacter pylori antibodies, and gastric cancer risk: a pooled analysis of prospective studies in China, Japan, and Korea. Int J Cancer. 2017;140(3):591–9.CrossRef Wang TY, Cai H, Sasazuki S, Tsugane S, Zheng W, Cho ER, et al. Fruit and vegetable consumption, Helicobacter pylori antibodies, and gastric cancer risk: a pooled analysis of prospective studies in China, Japan, and Korea. Int J Cancer. 2017;140(3):591–9.CrossRef
6.
go back to reference Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021;71(3):264–79.CrossRef Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021;71(3):264–79.CrossRef
7.
go back to reference Rausei S, Lianos GD. Treatment of gastric cancer. Cancers (Basel). 2020;12(9):2627. Rausei S, Lianos GD. Treatment of gastric cancer. Cancers (Basel). 2020;12(9):2627.
8.
go back to reference Fornaro L, Vasile E, Aprile G, Goetze TO, Vivaldi C, Falcone A, et al. Locally advanced gastro-oesophageal cancer: recent therapeutic advances and research directions. Cancer Treat Rev. 2018;69:90–100.CrossRef Fornaro L, Vasile E, Aprile G, Goetze TO, Vivaldi C, Falcone A, et al. Locally advanced gastro-oesophageal cancer: recent therapeutic advances and research directions. Cancer Treat Rev. 2018;69:90–100.CrossRef
9.
go back to reference Rabenstein T, May A, Gossner L, Manner H, Pech O, Gunter E, et al. Invisible gastric carcinoma detected by random biopsy: long-term results after photodynamic therapy. Endoscopy. 2008;40(11):899–904.CrossRef Rabenstein T, May A, Gossner L, Manner H, Pech O, Gunter E, et al. Invisible gastric carcinoma detected by random biopsy: long-term results after photodynamic therapy. Endoscopy. 2008;40(11):899–904.CrossRef
10.
go back to reference Raab O. Uber die wirkung fluoreszierender stoffe auf infusorien. Z Biol. 1900;39:524–46. Raab O. Uber die wirkung fluoreszierender stoffe auf infusorien. Z Biol. 1900;39:524–46.
11.
go back to reference Li WP, Yen CJ, Wu BS, Wong TW. Recent advances in photodynamic therapy for deep-seated tumors with the aid of nanomedicine. Biomedicines. 2021;9(1):69. Li WP, Yen CJ, Wu BS, Wong TW. Recent advances in photodynamic therapy for deep-seated tumors with the aid of nanomedicine. Biomedicines. 2021;9(1):69.
12.
go back to reference Lan M, Zhao S, Liu W, Lee CS, Zhang W, Wang P. Photosensitizers for photodynamic therapy. Adv Healthc Mater. 2019;8(13):e1900132.CrossRef Lan M, Zhao S, Liu W, Lee CS, Zhang W, Wang P. Photosensitizers for photodynamic therapy. Adv Healthc Mater. 2019;8(13):e1900132.CrossRef
13.
go back to reference Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011;61(4):250–81.CrossRef Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011;61(4):250–81.CrossRef
14.
go back to reference Oinuma T, Nakamura T, Nishiwaki Y. Report on the national survey of photodynamic therapy (PDT) for gastric cancer in Japan (a secondary publication). Laser Ther. 2016;25(2):87–98.CrossRef Oinuma T, Nakamura T, Nishiwaki Y. Report on the national survey of photodynamic therapy (PDT) for gastric cancer in Japan (a secondary publication). Laser Ther. 2016;25(2):87–98.CrossRef
15.
go back to reference Ma CH, Ma HH, Deng XB, Yu R, Song KW, Wei KK, et al. Photodynamic therapy in combination with chemotherapy, targeted, and immunotherapy as a successful therapeutic approach for advanced gastric adenocarcinoma: a case report and literature review. Photobiomod Photomed. 2022;40(5):308–14. Ma CH, Ma HH, Deng XB, Yu R, Song KW, Wei KK, et al. Photodynamic therapy in combination with chemotherapy, targeted, and immunotherapy as a successful therapeutic approach for advanced gastric adenocarcinoma: a case report and literature review. Photobiomod Photomed. 2022;40(5):308–14.
16.
go back to reference Casas A. Clinical uses of 5-aminolaevulinic acid in photodynamic treatment and photodetection of cancer: a review. Cancer Lett. 2020;490:165–73.CrossRef Casas A. Clinical uses of 5-aminolaevulinic acid in photodynamic treatment and photodetection of cancer: a review. Cancer Lett. 2020;490:165–73.CrossRef
17.
go back to reference Zhang J, Jiang C, Figueiro Longo JP, Azevedo RB, Zhang H, Muehlmann LA. An updated overview on the development of new photosensitizers for anticancer photodynamic therapy. Acta Pharm Sin B. 2018;8(2):137–46.CrossRef Zhang J, Jiang C, Figueiro Longo JP, Azevedo RB, Zhang H, Muehlmann LA. An updated overview on the development of new photosensitizers for anticancer photodynamic therapy. Acta Pharm Sin B. 2018;8(2):137–46.CrossRef
18.
go back to reference Wang XB, Hu JM, Wang P, Zhang SL, Liu YC, Xiong WL, et al. Analysis of the in vivo and in vitro effects of photodynamic therapy on breast cancer by using a sensitizer, sinoporphyrin sodium. Theranostics. 2015;5(7):772–86.CrossRef Wang XB, Hu JM, Wang P, Zhang SL, Liu YC, Xiong WL, et al. Analysis of the in vivo and in vitro effects of photodynamic therapy on breast cancer by using a sensitizer, sinoporphyrin sodium. Theranostics. 2015;5(7):772–86.CrossRef
19.
go back to reference Shi R, Li C, Jiang ZH, Li WF, Wang AP, Wei JF. Preclinical study of antineoplastic sinoporphyrin sodium-PDT via in vitro and in vivo models. Molecules. 2017;22(1):112. Shi R, Li C, Jiang ZH, Li WF, Wang AP, Wei JF. Preclinical study of antineoplastic sinoporphyrin sodium-PDT via in vitro and in vivo models. Molecules. 2017;22(1):112.
20.
go back to reference Xiong WL, Wang XB, Hu JM, Liu YC, Liu QH, Wang P. Comparative study of two kinds of repeated photodynamic therapy strategies in breast cancer by using a sensitizer, sinoporphyrin sodium. J Photochem Photobiol B. 2016;160:299–305.CrossRef Xiong WL, Wang XB, Hu JM, Liu YC, Liu QH, Wang P. Comparative study of two kinds of repeated photodynamic therapy strategies in breast cancer by using a sensitizer, sinoporphyrin sodium. J Photochem Photobiol B. 2016;160:299–305.CrossRef
21.
go back to reference Zhu B, Li SX, Yu L, Hu W, Sheng DD, Hou J, et al. Inhibition of autophagy with chloroquine enhanced sinoporphyrin sodium mediated photodynamic therapy-induced apoptosis in human colorectal cancer cells. Int J Biol Sci. 2019;15(1):12–23.CrossRef Zhu B, Li SX, Yu L, Hu W, Sheng DD, Hou J, et al. Inhibition of autophagy with chloroquine enhanced sinoporphyrin sodium mediated photodynamic therapy-induced apoptosis in human colorectal cancer cells. Int J Biol Sci. 2019;15(1):12–23.CrossRef
22.
go back to reference Liu YC, Wang P, Liu QH, Wang XB. Sinoporphyrin sodium triggered sono-photodynamic effects on breast cancer both in vitro and in vivo. Ultrason Sonochem. 2016;31:437–48.CrossRef Liu YC, Wang P, Liu QH, Wang XB. Sinoporphyrin sodium triggered sono-photodynamic effects on breast cancer both in vitro and in vivo. Ultrason Sonochem. 2016;31:437–48.CrossRef
23.
go back to reference Yano S, Hirohara S, Obata M, Hagiya Y, Ogura S, Ikeda A, et al. Current states and future views in photodynamic therapy. J Photoch Photobio C. 2011;12(1):46–67.CrossRef Yano S, Hirohara S, Obata M, Hagiya Y, Ogura S, Ikeda A, et al. Current states and future views in photodynamic therapy. J Photoch Photobio C. 2011;12(1):46–67.CrossRef
24.
go back to reference Brown SB, Brown EA, Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 2004;5(8):497–508.CrossRef Brown SB, Brown EA, Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 2004;5(8):497–508.CrossRef
25.
go back to reference Jiang DL, Yang Z, Liu GX, Wu K, Fan J, Wu D, et al. A novel 450-nm blue laser system for surgical applications: efficacy of specific laser-tissue interactions in bladder soft tissue. Lasers Med Sci. 2019;34(4):807–13.CrossRef Jiang DL, Yang Z, Liu GX, Wu K, Fan J, Wu D, et al. A novel 450-nm blue laser system for surgical applications: efficacy of specific laser-tissue interactions in bladder soft tissue. Lasers Med Sci. 2019;34(4):807–13.CrossRef
26.
go back to reference Xu X, Jiang DL, Liu GX, Wu K, Fan J, Wu D, et al. A novel 450 nm semiconductor blue laser system for application in colon endoscopic surgery: an ex vivo study of laser-tissue interactions. Photobiomodul Photomed Laser Surg. 2019;37(1):25–30.CrossRef Xu X, Jiang DL, Liu GX, Wu K, Fan J, Wu D, et al. A novel 450 nm semiconductor blue laser system for application in colon endoscopic surgery: an ex vivo study of laser-tissue interactions. Photobiomodul Photomed Laser Surg. 2019;37(1):25–30.CrossRef
27.
go back to reference Xu X, Jiang D, Liu G, Mu L, Zeng J, Yang L, et al. In vitro evaluation of the safety and efficacy of a high-power 450-nm semiconductor blue laser in the treatment of benign prostate hyperplasia. Lasers Med Sci. 2022;37(1):555–61.CrossRef Xu X, Jiang D, Liu G, Mu L, Zeng J, Yang L, et al. In vitro evaluation of the safety and efficacy of a high-power 450-nm semiconductor blue laser in the treatment of benign prostate hyperplasia. Lasers Med Sci. 2022;37(1):555–61.CrossRef
28.
go back to reference Schaberle FA. Assessment of the actual light dose in photodynamic therapy. Photodiagnosis Photodyn Ther. 2018;23:75–7.CrossRef Schaberle FA. Assessment of the actual light dose in photodynamic therapy. Photodiagnosis Photodyn Ther. 2018;23:75–7.CrossRef
29.
go back to reference Thrift AP, El-Serag HB. Burden of gastric cancer. Clin Gastroenterol Hepatol. 2020;18(3):534–42.CrossRef Thrift AP, El-Serag HB. Burden of gastric cancer. Clin Gastroenterol Hepatol. 2020;18(3):534–42.CrossRef
30.
go back to reference Collaborators GBDSC. The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017. Lancet. Gastroenterol Hepatol. 2020;5(1):42–54. Collaborators GBDSC. The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017. Lancet. Gastroenterol Hepatol. 2020;5(1):42–54.
31.
go back to reference Ono H, Yao KS, Fujishiro M, Oda I, Uedo N, Nimura S, et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition). Dig Endosc. 2021;33(1):4–20.CrossRef Ono H, Yao KS, Fujishiro M, Oda I, Uedo N, Nimura S, et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition). Dig Endosc. 2021;33(1):4–20.CrossRef
32.
go back to reference Choi IJ, Lee JH, Kim YI, Kim CG, Cho SJ, Lee JY, et al. Long-term outcome comparison of endoscopic resection and surgery in early gastric cancer meeting the absolute indication for endoscopic resection. Gastrointest Endosc. 2015;81(2):333–341.e331.CrossRef Choi IJ, Lee JH, Kim YI, Kim CG, Cho SJ, Lee JY, et al. Long-term outcome comparison of endoscopic resection and surgery in early gastric cancer meeting the absolute indication for endoscopic resection. Gastrointest Endosc. 2015;81(2):333–341.e331.CrossRef
33.
go back to reference Cats A, Jansen EPM, van Grieken NCT, Sikorska K, Lind P, Nordsmark M, et al. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial. Lancet Oncol. 2018;19(5):616–28.CrossRef Cats A, Jansen EPM, van Grieken NCT, Sikorska K, Lind P, Nordsmark M, et al. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial. Lancet Oncol. 2018;19(5):616–28.CrossRef
34.
go back to reference Namikawa T, Yatabe T, Inoue K, Shuin T, Hanazaki K. Clinical applications of 5-aminolevulinic acid-mediated fluorescence for gastric cancer. World J Gastroenterol. 2015;21(29):8769–75.CrossRef Namikawa T, Yatabe T, Inoue K, Shuin T, Hanazaki K. Clinical applications of 5-aminolevulinic acid-mediated fluorescence for gastric cancer. World J Gastroenterol. 2015;21(29):8769–75.CrossRef
35.
go back to reference Nakamura T, Oinuma T, Yamagishi H, Masuyama H, Terano A. Evaluation of a novel high-resolution magnifying videoendoscope that is capable of photodynamic diagnosis and therapy for gastric cancer. Photodiagn Photodyn. 2015;12(1):115–22.CrossRef Nakamura T, Oinuma T, Yamagishi H, Masuyama H, Terano A. Evaluation of a novel high-resolution magnifying videoendoscope that is capable of photodynamic diagnosis and therapy for gastric cancer. Photodiagn Photodyn. 2015;12(1):115–22.CrossRef
36.
go back to reference Zhou Z, Song J, Nie L, Chen X. Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy. Chem Soc Rev. 2016;45(23):6597–626.CrossRef Zhou Z, Song J, Nie L, Chen X. Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy. Chem Soc Rev. 2016;45(23):6597–626.CrossRef
37.
go back to reference Zhao L, Li J, Su Y, Yang L, Chen L, Qiang L, et al. MTH1 inhibitor amplifies the lethality of reactive oxygen species to tumor in photodynamic therapy. Sci Adv. 2020;6(10):eaaz0575.CrossRef Zhao L, Li J, Su Y, Yang L, Chen L, Qiang L, et al. MTH1 inhibitor amplifies the lethality of reactive oxygen species to tumor in photodynamic therapy. Sci Adv. 2020;6(10):eaaz0575.CrossRef
38.
go back to reference Dewaele M, Martinet W, Rubio N, Verfaillie T, de Witte PA, Piette J, et al. Autophagy pathways activated in response to PDT contribute to cell resistance against ROS damage. J Cell Mol Med. 2011;15(6):1402–14.CrossRef Dewaele M, Martinet W, Rubio N, Verfaillie T, de Witte PA, Piette J, et al. Autophagy pathways activated in response to PDT contribute to cell resistance against ROS damage. J Cell Mol Med. 2011;15(6):1402–14.CrossRef
39.
go back to reference Zhou J, Li XY, Liu YJ, Feng J, Wu Y, Shen HM, et al. Full-coverage regulations of autophagy by ROS: from induction to maturation. Autophagy. 2022;18(6):1240–55.CrossRef Zhou J, Li XY, Liu YJ, Feng J, Wu Y, Shen HM, et al. Full-coverage regulations of autophagy by ROS: from induction to maturation. Autophagy. 2022;18(6):1240–55.CrossRef
40.
go back to reference Scherz-Shouval R, Elazar Z. ROS, mitochondria and the regulation of autophagy. Trends Cell Biol. 2007;17(9):422–7.CrossRef Scherz-Shouval R, Elazar Z. ROS, mitochondria and the regulation of autophagy. Trends Cell Biol. 2007;17(9):422–7.CrossRef
41.
go back to reference Song C, Xu W, Wu H, Wang X, Gong Q, Liu C, et al. Photodynamic therapy induces autophagy-mediated cell death in human colorectal cancer cells via activation of the ROS/JNK signaling pathway. Cell Death Dis. 2020;11(10):938.CrossRef Song C, Xu W, Wu H, Wang X, Gong Q, Liu C, et al. Photodynamic therapy induces autophagy-mediated cell death in human colorectal cancer cells via activation of the ROS/JNK signaling pathway. Cell Death Dis. 2020;11(10):938.CrossRef
42.
go back to reference Mao W, Sun Y, Zhang H, Cao L, Wang J, He P. A combined modality of carboplatin and photodynamic therapy suppresses epithelial-mesenchymal transition and matrix metalloproteinase-2 (MMP-2)/MMP-9 expression in HEp-2 human laryngeal cancer cells via ROS-mediated inhibition of MEK/ERK signalling pathway. Lasers Med Sci. 2016;31(8):1697–705.CrossRef Mao W, Sun Y, Zhang H, Cao L, Wang J, He P. A combined modality of carboplatin and photodynamic therapy suppresses epithelial-mesenchymal transition and matrix metalloproteinase-2 (MMP-2)/MMP-9 expression in HEp-2 human laryngeal cancer cells via ROS-mediated inhibition of MEK/ERK signalling pathway. Lasers Med Sci. 2016;31(8):1697–705.CrossRef
43.
go back to reference Huang LY, Lin HD, Chen Q, Yu LH, Bai DQ. MPPa-PDT suppresses breast tumor migration/invasion by inhibiting Akt-NF-kappa B-dependent MMP-9 expression via ROS. BMC Cancer. 2019;19(1):1159.CrossRef Huang LY, Lin HD, Chen Q, Yu LH, Bai DQ. MPPa-PDT suppresses breast tumor migration/invasion by inhibiting Akt-NF-kappa B-dependent MMP-9 expression via ROS. BMC Cancer. 2019;19(1):1159.CrossRef
44.
go back to reference Alzeibak R, Mishchenko TA, Shilyagina NY, Balalaeva IV, Vedunova MV, Krysko DV. Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future. J Immunother Cancer. 2021;9(1):e001926. Alzeibak R, Mishchenko TA, Shilyagina NY, Balalaeva IV, Vedunova MV, Krysko DV. Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future. J Immunother Cancer. 2021;9(1):e001926.
45.
go back to reference Tan L, Shen X, He Z, Lu Y. The role of photodynamic therapy in triggering cell death and facilitating antitumor immunology. Front Oncol. 2022;12:863107.CrossRef Tan L, Shen X, He Z, Lu Y. The role of photodynamic therapy in triggering cell death and facilitating antitumor immunology. Front Oncol. 2022;12:863107.CrossRef
46.
go back to reference Lu Y, Xu F, Wang Y, Shi C, Sha Y, He G, et al. Cancer immunogenic cell death via photo-pyroptosis with light-sensitive Indoleamine 2,3-dioxygenase inhibitor conjugate. Biomaterials. 2021;278:121167.CrossRef Lu Y, Xu F, Wang Y, Shi C, Sha Y, He G, et al. Cancer immunogenic cell death via photo-pyroptosis with light-sensitive Indoleamine 2,3-dioxygenase inhibitor conjugate. Biomaterials. 2021;278:121167.CrossRef
Metadata
Title
A novel 450-nm laser-mediated sinoporphyrin sodium-based photodynamic therapy induces autophagic cell death in gastric cancer through regulation of the ROS/PI3K/Akt/mTOR signaling pathway
Authors
Xing Li
Lijiang Gu
Yuhang Chen
Xiaobing Wang
Yibo Mei
Jinlai Zhou
Minghai Ma
Jianbin Ma
Yue Chong
Xinyang Wang
Peng Guo
Dalin He
Jin Zeng
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2022
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-022-02676-8

Other articles of this Issue 1/2022

BMC Medicine 1/2022 Go to the issue